FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, the use of HMEC-1 cells for measuring FcRn-mediated IgG recycling, and the assays used to support the development of next-generation biologics and FcRn-targeted therapeutics.
1/ What is the biological function of FcRn?
Neonatal Fc receptor for IgG (FcRn) is a heterodimeric protein similar in structure to MHC class I that binds to the Fc region of immunoglobulin G (IgG). It consists of the FcRn heavy chain (encoded by FCGRT) associated with β2-microglobulin (B2M) and is expressed in over 25 tissue types, with high expression levels observed in the spleen and intestine.
FcRn contributes to effective humoral immunity by protecting IgG antibodies from degradation, recycling them and extending their half-life in circulation. It also regulates the homeostasis of serum albumin.
FcRn plays a vital role in regulating the level of albumin and IgG antibodies in circulation by binding albumin and the Fc region of an IgG at low pH (about pH 6.0) in endosomes. It then diverts them from lysosomal degradation and recycles them for release into the neutral pH (pH 7.0 to 7.4) of the extracellular compartment.
2/ How is FcRn function exploited for antibody engineering?
The IgG antibody stabilisation function of FcRn can be exploited when engineering therapeutic antibodies: mutations introduced into the Fc fragment can increase binding to FcRn, which improves their half-life and therefore their therapeutic efficacy.
Measuring FcRn-dependent IgG antibody recycling is therefore a key step in developing and characterising novel therapeutic antibodies, Fc-engineered biologics and biosimilars. Researchers often use HMEC-1 cells for this purpose.
3/ Why are HMEC-1 cells used to perform IgG antibody recycling assays?
The HMEC-1 cell line (human microvascular endothelial cells, immortalised) is one of the most widely used in vitro models for evaluating the internalisation and recycling of therapeutic IgG antibodies. As an endothelial cell system, it is highly physiologically relevant because endothelial cells are considered one of the major sites of FcRn-mediated IgG recycling in vivo. HMEC-1 cells express the neonatal Fc receptor (FcRn), enabling the study of key processes involved in IgG trafficking, including cellular uptake, endosomal sorting and recycling back to the cell surface. This makes them well suited for assessing the recycling efficiency of therapeutic antibodies and engineered Fc variants.
Together, these characteristics make HMEC-1 cells a valuable platform for comparing antibody candidates, screening Fc-engineered variants and studying FcRn-mediated recycling mechanisms.
4/ How does the FcRn: IgG Recycling HMEC-1 Cell Pool work?
BPS Bioscience’s cell-based IgG antibody recycling assays are designed to evaluate FcRn-mediated antibody trafficking and recycling activity in physiologically relevant HMEC-1 cells. Sometimes termed HERA (human endothelial cell-based recycling assay), these assays support lead optimisation and functional characterisation workflows by providing quantitative data on IgG binding to FcRn and recycling behaviour.
The assays use HMEC-1 cells genetically engineered to express FcRn, for robust, stable expression of FCGRT and B2M. The cells were extensively validated by measuring the recycling of well-known IgG1 antibodies such as nivolumab, rituximab, trastuzumab, basiliximab and alirocumab.
5/ When is it desirable to block IgG binding to FcRn?
FcRn itself is a therapeutic target for some autoimmune diseases since disrupting the FcRn/IgG interaction is expected to increase IgG antibody clearance, including clearance of autoantibodies, thereby decreasing their concentration in patients. The first FDA-approved drug targeting FcRn (efgartigimod) is an Fc fragment decoy that provided proof-of-concept and is now used to treat the autoimmune disease myasthenia gravis.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
